Pharma Struggling To Assimilate Flood Of Clinical Trial Data
Executive Summary
Big data may be prolonging development times for new pharmaceuticals, as companies struggle to cope with diverse digital applications and clinical trial protocol changes.
You may also be interested in...
A Whistle-Stop Tour of 2017 – From An EU Regulatory Point Of View
This past year was a busy one for regulators and regulated alike in the EU. We take a look at some of the key events from 2017.
Pharma Could Do Better With Data, Say IBM, McLaren
The great and good of the pharmaceutical industry have again been speaking about the big opportunities that big data provides, but senior executives from IBM Watson Health and Formula 1 giant McLaren believe the sector should be doing more.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.